VG · Venture Global, Inc.

Current Thesis

Venture Global’s liquefied natural gas (LNG) expansion supports a recovery thesis that succeeds on a weekly close above the $17.51 annual high and fails on a weekly close below the reclaimed $15.12 July high. Those are research conditions: the supplied market series records a $15.80 close on 2026-09-11 and a $17.51 trailing annual high; the 2026-08-30 published review identifies $15.12 as the 2026-07-24 intraday high.

The September close changes the earlier finding that price had failed to follow operating improvements: the market now stands above that July reference. As an inference, the narrative is maturing — Scotiabank’s 2026-09-10 target increase extends the analyst reassessment already documented in August, rather than establishing a new operating catalyst. Scotiabank raised its target to $16 from $15 while retaining Sector Perform. Benzinga analyst-action record

Bullish and bearish views on Venture Global, Inc.

The model's bull view on Venture Global, Inc. (VG), in brief: Operating growth supports the story. Venture Global reported second-quarter adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $2.5 billion, up 79% year over year, on 2026-08-11. Management raised its full-year 2026 adjusted EBITDA guidance to… The bear view: Financing remains an active dependency. On 2026-09-03, Venture Global announced a $3 billion, 364-day senior secured revolving credit facility at its subsidiary. The announcement establishes financing availability; it does not establish the amount drawn or operating cash… Both cases follow in full.

Bull Case

• Operating growth supports the story. Venture Global reported second-quarter adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $2.5 billion, up 79% year over year, on 2026-08-11. Management raised its full-year 2026 adjusted EBITDA guidance to $8.7–9.1 billion. Company results
• Price has cleared July resistance. The 2026-09-11 adjusted close of $15.80 exceeds the $15.12 high dated 2026-07-24 in the August published review. This supports the recovery interpretation; a weekly close below $15.12 would invalidate that interpretation.
• Analyst support remains visible. TipRanks records UBS reiterating its $21 target on 2026-09-11 and Goldman Sachs reiterating $18 on 2026-09-10. These are attributed analyst forecasts, not evidence of institutional purchases. TipRanks analyst history

Bear Case

• Financing remains an active dependency. On 2026-09-03, Venture Global announced a $3 billion, 364-day senior secured revolving credit facility at its subsidiary. The announcement establishes financing availability; it does not establish the amount drawn or operating cash generation. Failure to refinance any outstanding balance at maturity would confirm the funding risk. Company announcement listing
• Squeeze evidence remains internally inconsistent. The 2026-08-30 published review juxtaposed Benzinga’s 2026-08-26 claim of more than 80% of float sold short with StockAnalysis figures retrieved on 2026-08-30 showing 8.19% and 2.75 days to cover. The settlement date was not supplied, and neither observation establishes September positioning. The discrepancy leaves the squeeze claim unsupported.
• Contracting limits the shortage inference. Management reported on 2026-08-11 that 91% of available 2026 cargoes were contracted. A generalized gas-shortage headline therefore does not establish an equivalent increase in company revenue; weaker realized fees or reduced guidance would contradict that earnings extension. Company results

Setup & Price Structure

The supplied adjusted market series shows a three-month price increase of 21.0% and a 14-period relative strength index (RSI) reading of 68.9 as of 2026-09-11. The $15.80 reference close remains 9.8% below the $17.51 trailing annual high. These measure price momentum; they do not identify the buyers or establish crowding.

The reclaimed $15.12 July high defines the recovery test. A weekly close above $17.51 would complete the stated price case before invalidation; a weekly close below $15.12 would end it. The supplied observations contain no moving-average value or trading-volume series, so they cannot establish a rising-average support level or expanding participation.

Catalyst Calendar (next 30 days)

• 2026-09-30 — Dividend payment date. The same declaration schedules payment of $0.04 per share. Payment would confirm execution of the declared distribution, without confirming the production outlook. Company declaration

No company-confirmed earnings or operational-update date within the next 30 days was identified in the investor calendar checked on 2026-09-13. The previously published October operational-update estimate remains unconfirmed and is not assigned as the catalyst date. Company events calendar

Elapsed catalysts

• 2026-09-15 — Dividend record date. The 2026-08-11 declaration sets this date for the third-quarter dividend. It is an administrative event and does not resolve the operating thesis. Company declaration (passed 5d ago)

What Would Change Our Mind

Loss of the reclaimed July high would overturn the September recovery finding: a weekly close below $15.12 is the published thesis-break condition. The fundamental counterpart is a reduction below the $8.7 billion lower end of management’s 2026-08-11 full-year adjusted EBITDA guidance. The price condition remains independently sufficient. Guidance release

Correlation Notes

This remains a single-company LNG case. Management’s 2026-08-11 guidance assumes liquefaction fees of $12.50–13.50 per million British thermal units for remaining unsold 2026 cargoes. That company fee assumption is not interchangeable with a European benchmark gas price or a crude-oil quote. Company outlook

No matched peer-return series accompanies the 2026-09-11 price observations. The evidence therefore supports no measured correlation claim with LNG peers, oil producers or artificial-intelligence infrastructure equities.